Tag: par_health

Par Health Recalls Two Lots of Brevital Sodium Over Cellulose Particulate Matter

14 Oct 2026 4:46 p.m.

The nationwide recall of Brevital Sodium 500 mg/vial, distributed to wholesalers between July 2025 and May 2026, carries a risk of life-threatening adverse health consequences including pulmonary emboli.

Health Business Law Enforcement Medical Science Legal USA Social Issues Product Recall Par Health Brevital Sodium Methohexital Sodium for Injection US Food and Drug Administration Particulate Matter Rochester, Michigan Food Recalls FDA Drugs Methohexital Sodium MedWatch
Par Health Recalls 22 Lots of Argatroban Injection Nationwide Over Particulate Matter

14 Oct 2026 4:56 p.m.

The voluntary recall to the hospital/user level covers lots distributed nationwide between December 30, 2024, and May 5, 2026, after cellulose, polystyrene, polyethylene terephthalate, stopper material and possibly stainless steel were detected in certain lots.

Health Business Law Enforcement Medical Science Legal Social Issues Par Health Argatroban Injection Product Recall US Food and Drug Administration Particulate Matter Rochester, Michigan Pulmonary Emboli Food Recalls FDA Drugs Heparin-Induced Thrombocytopenia MedWatch
Par Health Recalls Two Lots of Dexmedetomidine Injection Over Particulate Matter

22 Sep 2026 4:39 p.m. · Source: US Food and Drug Administration

Par Health is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection to the hospital level after cellulose or stopper material was found in the product.

Health Business Law Enforcement Medical Science Legal Product Recall Par Health Dexmedetomidine HCl Sodium Chloride Injection US Food and Drug Administration Particulate Matter Pulmonary Emboli Food Recalls FDA Drugs
Par Health Recalls Two Lots of Dexmedetomidine Injection Over Particulate Matter

22 Sep 2026 7:53 a.m. · Source: US Food and Drug Administration

Par Health is recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection to the hospital level after cellulose or stopper material was found in the product.

Health Business Law Enforcement USA Medical Science Legal Social Issues Product Recall Dexmedetomidine HCl Par Health US Food and Drug Administration Particulate Matter MedWatch Sodium Chloride Injection Food Recalls FDA Drugs